Is SUPN stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Supernus Pharmaceuticals 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $8.45, you would have made a profit of $25.40 per share or 300.59%
Yes, the average daily trading liquidity for Supernus Pharmaceuticals is $15.43 million. You should therefore be able to get in and out of your positions relatively fast.
Supernus Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 2.38, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Supernus Pharmaceuticals to be low [0.3 out of 1]